First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.
| Publicado en: | New England Journal of Medicine Vol. 395; no. 8; pp. 756 - 767 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
New England Journal of Medicine
8/20/2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=196430968&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 196430968 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00284793 NEJ jtl: New England Journal of Medicine issn: 00284793 maglogo: N pubinfo: dt: 8/20/2026 vid: 395 iid: 8 pid: 388 pub: New England Journal of Medicine place: Waltham, Massachusetts artinfo: ui: 196430968 10.1056/NEJMoa2604461 196430968 ppf: 756 ppct: 11 formats: tig: atl: First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations. aug: au: Zhou, Caicun Greillier, L. Liu, G. John, T. Xing, L. Kowalski, D. Memmott, R. M. Yazici, O. Sun, M. Shu, C. A. Pons-Tostivint, E. Fan, Y. Fernandez-Hinojal, G. Shum, E. Wang, M. Bertolini, F. Camidge, D. R. Zhou, Chengzhi Doucet, L. Hong, Q. affil: Shanghai East Hospital, Shanghai sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|